PORTAL VEIN THROMBOSIS
Clinical trials for PORTAL VEIN THROMBOSIS explained in plain language.
Never miss a new study
Get alerted when new PORTAL VEIN THROMBOSIS trials appear
Sign up with your email to follow new studies for PORTAL VEIN THROMBOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New blood thinner may reduce deadly bleeding in cirrhosis patients
Disease control Not yet recruitingThis study tests whether a blood thinner called rivaroxaban can safely prevent further bleeding in people with liver cirrhosis who have both high-risk varices (enlarged veins) and a blood clot in the portal vein. About 175 participants will receive the drug starting 48 hours afte…
Matched conditions: PORTAL VEIN THROMBOSIS
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 26, 2026 08:04 UTC
-
Massive study aims to predict deadly clots in liver patients
Knowledge-focused Not yet recruitingThis study will follow about 2,500 adults with liver cirrhosis to learn who develops dangerous blood clots in the liver's main vein. Researchers will review past cases and track new patients for two years to build a prediction tool, measure how clots affect survival, and see if b…
Matched conditions: PORTAL VEIN THROMBOSIS
Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 07:25 UTC